Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2009, Article ID 527208, 4 pages
Review Article

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)

1Division of Infectious Diseases, New Jersey Medical School, University of Medicine and Dentistry of New Jersey (UMDNJ), Newark, NJ 07101, USA
2Veteran's Affairs New Jersey Healthcare System, 385 Tremont Avenue, 111-ID, East Orange, NJ 07018, USA
3Allergy, Immunology, and Infectious Diseases, Robert Wood Johnson University Hospital, New Brunswick, NJ 08903, USA

Received 11 June 2009; Accepted 1 October 2009

Academic Editor: Joseph Falkinham

Copyright © 2009 Eric Gomez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. W. Herr and A. Morales, “History of Bacillus Calmette-Guérin and bladder cancer: an immunotherapy success story,” The Journal of Urology, vol. 178, no. 1, pp. 53–56, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. D. L. Lamm, “Complications of Bacillus Calmette-Guérin immunotherapy,” Urologic Clinics of North America, vol. 19, no. 3, pp. 565–572, 1992. View at Google Scholar
  3. A. J. Mas, M. Romera, and J. M. Valverde Garcia, “Articular manifestations after the administration of intravesical BCG,” Joint Bone Spine, vol. 69, pp. 92–93, 2002. View at Google Scholar
  4. A. H. Razack, “Bacillus Calmette-Guérin and bladder cancer,” Asian Journal of Surgery, vol. 30, no. 4, pp. 302–309, 2007. View at Google Scholar
  5. K. A. Nadasy, R. S. Patel, M. Emmett et al., “Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma,” Southern Medical Journal, vol. 101, no. 1, pp. 91–95, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. D. L. Lamm, A. Steg, L. Boccon-Gibod et al., “Complications of Bacillus Calmette-Guérin immunotherapy: review of 2602 patients and comparison of chemotherapy complications,” Progress in Clinical Biological Research, vol. 310, pp. 355–355, 1989. View at Google Scholar
  7. G. Clavel, F. Grados, P. Lefauveau, and P. Fardellone, “Osteoarticular side effects of BCG therapy,” Joint Bone Spine, vol. 73, no. 1, pp. 24–28, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. W. J. Leach and D. S. Halpin, “Mycobacterium bovis infection of a total hip arthroplasty: a case report,” Journal of Bone and Joint Surgery. British, vol. 75, no. 4, pp. 661–662, 1993. View at Google Scholar
  9. P. Chazerain, N. Desplaces, P. Mamoudy, P. Leonard, and J. M. Ziza, “Prosthetic total knee infection with a Bacillus Calmette-Guérin (BCG) strain after BCG therapy for bladder cancer,” Journal of Rheumatology, vol. 20, no. 12, pp. 2171–2172, 1993. View at Google Scholar
  10. O. Reigstad and P. Siewers, “A total hip replacement infected with Mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guérin for bladder cancer,” Journal of Bone and Joint Surgery. British, vol. 90, no. 2, pp. 225–227, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. A. Segal and E. S. Krauss, “Infected total hip arthroplasty after intravesical Bacillus Calmette-Guérin therapy,” Journal of Arthroplasty, vol. 22, no. 5, pp. 759–762, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. C. E. Guerra, R. F. Betts, R. J. O'Keefe, and J. W. Shilling, “Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular Bacille Calmette-Guérin for bladder cancer,” Clinical Infectious Diseases, vol. 27, no. 3, pp. 639–640, 1998. View at Google Scholar
  13. L. Bowyer, R. R. Hall, J. Reading, and M. M. Marsh, “The persistence of Bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer,” British Journal of Urology, vol. 75, no. 2, pp. 188–192, 1995. View at Google Scholar
  14. A. Böhle, D. Kirsten, K. H. Schröder et al., “Clinical evidence of systemic persistence of Bacillus Calmette-Guérin: long-term pulmonary Bacillus Calmette-Guérin infection after intravesical therapy for bladder cancer and subsequent cystectomy,” The Journal of Urology, vol. 148, pp. 1894–1897, 1992. View at Google Scholar
  15. M. Marmor, N. Parnes, and S. Dekel, “Tuberculosis infection complicating total knee arthroplasty: report of 3 cases and review of the literature,” Journal of Arthroplasty, vol. 19, no. 3, pp. 397–400, 2004. View at Publisher · View at Google Scholar
  16. C. L. Lee, Y. S. Wei, Y. J. Ho, and C. H. Lee, “Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty,” The Knee, vol. 16, pp. 87–89, 2009. View at Google Scholar
  17. R. J. Spinner, D. J. Sexton, R. D. Goldner, and L. S. Levin, “Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis,” Journal of Arthroplasty, vol. 11, no. 2, pp. 217–222, 1996. View at Publisher · View at Google Scholar
  18. C. Durek, S. Rüsch-Gerdes, D. Jocham, and A. Böhle, “Sensitivity of BCG to modern antibiotics,” European Urology, vol. 37, supplement 1, pp. 21–25, 2000. View at Google Scholar
  19. D. R. Stone, N. A. Estes III, and M. S. Klempner, “Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with Bacille Calmette-Guérin,” Clinical Infectious Diseases, vol. 16, pp. 825–826, 1993. View at Google Scholar